Stat3 contributes to resistance toward BCR-ABL inhibitors...

Molecular Cancer Therapeutics 2008 / 10 Vol. 7; Iss. 10

Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance

Bewry, N. N., Nair, R. R., Emmons, M. F., Boulware, D., Pinilla-Ibarz, J., Hazlehurst, L. A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
7
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-08-0314
Date:
October, 2008
File:
PDF, 366 KB
english, 2008
Conversion to is in progress
Conversion to is failed